-

Miley Cyrus Joins Hims & Hers as Creative Advisor

Company Is Teaming Up With The Multi-Platinum Selling Recording Artist, Songwriter and Trailblazer to Shine a Spotlight On Personalized Skincare

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers, the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced Multi-Platinum Selling Recording Artist, Songwriter and Trailblazer Miley Cyrus has joined the Company as a Creative Advisor. In this role, the icon of authenticity will collaborate with the Company on the Hers line of prescription skincare products, beginning with a series of new advertising campaigns and social content.

“While I struggled a lot with my skin when I was younger, I’ve learned that there isn’t a one-size-fits-all skincare routine -- it needs to be personalized,” commented Miley Cyrus. “Hims & Hers makes the entire process incredibly simple, from the initial virtual consultation to the monthly subscription of products tailored just for me. In this new advisory role, I hope to work closely with the company and introduce my fans to an easier, more personalized skincare journey.”

Hims & Hers, which recently began trading on the New York Stock Exchange, offers personalized, high-quality solutions for issues related to primary care as well as mental health, sexual wellness, hair loss and skincare to a digitally native generation. The brand’s current selection of medical skincare services includes free telehealth consultations with licensed medical professionals discussing concerns such as acne and anti-aging, a suite of customizable prescription products and a collection of nonprescription options. The prescription skincare products available through Hers harness powerful ingredients such as tretinoin, clindamycin, azelaic acid, zinc pyrithione, and niacinamide in beautiful, easy-to-use packaging for a low monthly cost.

“For many consumers, skincare routines particularly related to acne or aging can feel daunting and ineffective,” noted Co-Founder and CEO Andrew Dudum. “We’re thrilled to have Miley, who is an incredibly outspoken and passionate businesswoman in her own right, supporting our efforts to bring personalized skincare to a larger audience.”

For additional details on the Hims & Hers skincare offering or to learn more about the brand’s partnership with Miley Cyrus, please visit www.forhers.com.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O'Connor
press@forhims.com

Hims & Hers

NYSE:HIMS

Release Summary
Miley Cyrus has joined Hims & Hers as a Creative Advisor beginning with a series of new advertising campaigns and social content.
Release Versions

Contacts

Linda O'Connor
press@forhims.com

More News From Hims & Hers

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, refe...

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health,...

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advance...
Back to Newsroom